|
IQVIA™ Real-World Insights Bibliography
| Burden of Hospitalizations and Outpatient Visits Associated With Moderate and Severe Acute Graft-Versus-Host Disease in Finland and Sweden: A Real-World Data Analysis |
| Author(s): Lorenzo Sabatelli, PhD,1 Mikko Keränen, MD, PhD,2 Elisabet Viayna, PhD,3 Montserrat Roset, BSc Stats,3 Nuria Lara, MD, MSc,3 Daniel Thunström, MSc Pharm,1 Minja Pfeiffer, PhD,1 Malin Nicklasson, MSc Pharm,4 Maija Itälä-Remes, MD, PhD5
|
| Affiliations(s): "1Incyte Biosciences International Sàrl, Morges, Switzerland; 2Helsinki University Hospital, Helsinki, Finland; 3IQVIA Real World Solutions, Barcelona, Spain; 4Department of Hematology and Coagulation, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 5Turku University Hospital, Turku, Finland "
|
Publication(s): Supportive Care in Cancer
|
| Document Type(s): Article, |
| Countries: Finland, Spain, Sweden, Switzerland, |
C:
Y: |
Health economics, Transplant,
2022 |
|
L:
A: |
English
Clinical setting: hospital, Observational study, Population Based Study, |
|
 |
| |
| |
|
Cost analysis of sequencing new agents for the treatment of chronic lymphocytic leukemia from the perspective of the Brazilian supplementary health system |
| Author(s): Leandro Brust (1), Celso Arrais (2), Fabiano Pombo (3), Diego Kashiura (4), Pedro Vitor Pereira Lima (4), Ana Travassos (5), Rafael Silva (5), Straus Tanaka (5) |
| Affiliations(s): 1: Dasa, Rio Grande do Sul, Brasil; 2: Universidade Federal de São Paulo, São Paulo, SP, Brasil; 3: Américas Centro de Oncologia Integrado, Rio de Janeiro, RJ, Brasil; 4: IQVIA Real World Insights Brazil, São Paulo, SP, Brasil; 5: AbbVie Brasil, São Paulo, SP, Brasil. |
Publication(s): J Bras Econ Saúde 2022;14(1):80-8
|
| Document Type(s): Article, |
| Countries: Brazil, |
| Click here for the abstract |
C:
Y: |
Health economics, Hematology,
2022 |
|
L:
A: |
Portuguese
Cost effectiveness, |
|
|
| |
| |
| Direct costs associated with lupus nephritis management in the Private Healthcare System in Brazil: an expert panel perspective |
| Author(s): Danielle O. Silva (1), Nathalie David (1), Bruce Y. Kano (2), Diego Kashiura (2), Odirlei A. Monticielo (3), André Hayata (4), Mariana R. Gazzotti (1), Graziela Bernardino (1) |
| Affiliations(s): 1: GSK, Rio de Janeiro, RJ, Brasil; 2: IQVIA Real World Insights, São Paulo, SP, Brazil; 3: Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; 4: Centro de Reumatologia Avançada, São Paulo, SP, Brazil |
Publication(s): J Bras Econ Saúde 2022;14(3):232-46
|
| Document Type(s): Article, |
| Countries: Brazil, |
| Click here for the abstract |
C:
Y: |
Dermatology, Health economics,
2022 |
|
L:
A: |
English
Cost analysis, |
|
|
| |
| |
| Budget impact analysis of Jivi® (damoctocog alfa pegol, BAY 94-9027) in severe Hemophilia A in Japan |
| Author(s): Teruhisa Fujii 1, Yuko Kidoguchi 2, Noriko Takahashi 2, Eric Yu 3, Dilinuer Ainiwaer 3, Aidan Byrne 4 (rwesheorj 3) |
| Affiliations(s): 1) Division of Blood Transfusion, Hiroshima University Hospital, Hiroshima, Japan
2) Market Access, Bayer Yakuhin, Ltd., Tokyo, Japan
3) IQVIA Solutions Japan K.K., Tokyo, Japan
4) IQVIA UK, London, UK |
Publication(s): Journal of Medical Economics
|
| Document Type(s): Article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Health economics,
2021 |
|
L:
A: |
English
Budget impact, |
|
|
| |
| |
| High‑Expenditure Disease in the EU‑28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes? |
| Author(s): Wolfgang Greiner, Keyur Patel, Christina-Jane Crossman-Barnes, Troels Vingtoft Rye-Andersen, Christian Hvid, Tom Vandebrouck |
| Affiliations(s): Department for Health Economics, Bielefeld University, Bielefeld, Germany; IQVIA Ltd, HEOR, London, UK; Novo Nordisk Region Europe Pharmaceuticals A/S, Copenhagen, Denmark; Novo Nordisk Region Europe Pharmaceuticals A/S, Brussels, Belgium |
Publication(s): PharmacoEconomics-Open. 2021 Jan; doi.org/10.1007/s41669-020-00253-4
|
| Document Type(s): Article, |
| Countries: Europe, |
| Click here for the abstract |
C:
Y: |
Diabetes, Health economics, Oncology,
2021 |
|
L:
A: |
English
Burden of illness, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Literature Review, Quality of life, Retrospective database analysis, Review, |
|
|
| |
| |
| Concerns, quality of life, access to care and productivity of the general population during the first 8 weeks of the coronavirus lockdown in Belgium and the Netherlands |
| Author(s): Hanne van Ballegooijen 1, Lucas Goossens 2, Ralph H Bruin 3, Renée Michels 3, Marieke Krol 3
|
| Affiliations(s): 1IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands. hanne.vanballegooijen@iqvia.com.
2Erasmus University Rotterdam, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands.
3IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands. |
Publication(s): 1 IQVIA, Herikerbergweg 314, 1101 CT Amsterdam, The Netherlands. 2 Erasmus University Rotterdam, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands
BMC Health Services Research (2021) 21:227
PMID: 33712010 PMCID: PMC7953179 DOI: 10.1186/s12913-021-06240-7
|
| Document Type(s): Article, |
| Countries: Netherlands , |
| Click here for the abstract |
C:
Y: |
Health economics, Health status & patient reported outcomes, Immunology and Vaccination,
2021 |
|
L:
A: |
English
Observational study, Patient questionnaire, Population Based Study, Public Health, Quality of life, Survey research, |
|
|
| |
| |
| The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type 2 Diabetes and Established Cardiovascular Disease |
| Author(s): Lars Holger Ehlers 1, Mark Lamotte 2, Sofia Monteiro 3, Susanne Sandgaard 4, Pia Holmgaard 4, Evan C Frary 4, Niels Ejskjaer 5 6 7 |
| Affiliations(s): 1Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
2IQVIA Real World Solutions, Zaventem, Belgium.
3IQVIA Real World Solutions, London, UK.
4Boehringer Ingelheim Danmark A/S, København Ø, Hovedstaden, Denmark.
5Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. n.ejskjaer@rn.dk.
6Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark. n.ejskjaer@rn.dk.
7Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark. n.ejskjaer@rn.dk. |
Publication(s): Diabetes Therapy https://doi.org/10.1007/s13300-021-01040-y
IQVIA HEOR Zaventem Brussels
PMID: 33856655 PMCID: PMC8099952 DOI: 10.1007/s13300-021-01040-y
|
| Document Type(s): |
| Countries: Denmark, |
| Click here for the abstract |
C:
Y: |
Diabetes, Health economics,
2021 |
|
L:
A: |
English
Clinical setting: Primary care, Cost effectiveness, |
|
|
| |
| |
| Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Portugal |
| Author(s): Nuno Marques 1, Laetitia Gerlier 2, Mafalda Ramos 3, Helder Pereira 4, Sérgia Rocha 5, Ana Catarina Fonseca 6, Ana André 7, Ricardo Melo 8, Eduard Sidelnikov 9 |
| Affiliations(s): 1Department of Cardiology, Centro Hospitalar e Universitário do Algarve, Faro, Portugal.
2IQVIA, Zaventem, Belgium.
3IQVIA, Zaventem, Belgium. Electronic address: mafalda.ramos@iqvia.com.
4Department of Cardiology, Hospital Garcia de Orta, Almada, Portugal.
5Department of Cardiology, Hospital de Braga, Braga, Portugal.
6Department of Neurology, Hospital de Santa Maria, Universidade de Lisboa, Lisboa, Portugal.
7Department of Neurology, Centro Hospitalar e Universitário do Algarve, Faro, Portugal.
8Amgen SA, Portugal.
9Amgen (Europe) GmbH, Rotkreuz, Switzerland. |
Publication(s): PMID: 33581948 DOI: 10.1016/j.repc.2020.05.019
IQVIA HEOR Zaventem Brussels
Revista Portuguesa de Cardiologia Volume 40, Issue 2, February 2021, Pages 109-115.
|
| Document Type(s): Article, |
| Countries: Portugal, |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease, Health economics,
2021 |
|
L:
A: |
English
Burden of illness, Clinical setting: Primary care, Prospective study, |
|
|
| |
| |
| Cost-effectiveness analysis of empagliflozin compared with glimepiride in patients with Type 2 diabetes in China |
| Author(s): Ahmed Salem 1, Peng Men 2 3, Mafalda Ramos 4, Yan-Jun Zhang 5, Anastasia Ustyugova 6, Mark Lamotte 7 |
| Affiliations(s): 1IQVIA, Real World Solutions, Zaventem 1930, Belgium.
2Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China.
3Institute for Drug Evaluation, Peking University Health Science Center, Beijing 100191, China.
4IQVIA, Global HEOR, Porto Salvo 2740-266, Portugal.
5Boehringer Ingelheim, Health Economics & Outcomes Research, Government Affairs & Market Access, Shanghai 200040, China.
6Boehringer Ingelheim, CardioMetabolism Respiratory, Ingelheim am Rhein 55216, Germany.
7IQVIA, Global HEOR, Zaventem 1930, Belgium. |
Publication(s): Journal of Comparative Effectiveness Research 2021 https://doi.org/10.2217/cer-2020-0284.
PMID: 33576249 DOI: 10.2217/cer-2020-0284
|
| Document Type(s): Article, |
| Countries: China, |
| Click here for the abstract |
C:
Y: |
Diabetes, Health economics,
2021 |
|
L:
A: |
English
Clinical setting: Primary care, Cost effectiveness, |
|
|
| |
| |
| Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China |
| Author(s): Ahmed Salem # 1, Heng Zhong # 2, Mafalda Ramos 1, Mark Lamotte 1, Hao Hu 3
|
| Affiliations(s): 1Real World Evidence, IQVIA, Zaventem, Belgium.
2R&D China, AstraZeneca R&D, Shanghai, China.
3Institute of Chinese Medical Sciences, University of Macau, Macau, China haohu@um.edu.mo.
#Contributed equally. |
Publication(s): BMJ Open 2021;11:e043664. doi:10.1136/bmjopen-2020-043664
e043664. doi:10.1136/bmjopen-2020-043664
PMID: 33910947 PMCID: PMC8094343 DOI: 10.1136/bmjopen-2020-043664
|
| Document Type(s): Article, |
| Countries: Belgium, China, |
| Click here for the abstract |
C:
Y: |
Health economics, Respiratory disease,
2021 |
|
L:
A: |
English
Clinical setting: Primary care, Cost effectiveness, |
|
|
| |
| |
 1 of 23 
|
|
